Literature DB >> 11503630

Oral transmucosal fentanyl and sufentanil for incident pain.

J Gardner-Nix.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11503630     DOI： 10.1016/s0885-3924(01)00321-9

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  5 in total

1.  Pharmacologic management of adult breakthrough cancer pain.

Authors:  Bruce Doulton
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

2.  Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.

Authors:  B Lennernäs; T Hedner; M Holmberg; S Bredenberg; C Nyström; H Lennernäs
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

Review 3.  Demographics, assessment and management of pain in the elderly.

Authors:  Mellar P Davis; Manish Srivastava
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Recent advances in the use of opioids for cancer pain.

Authors:  Joanne Droney; Julia Riley
Journal:  J Pain Res       Date:  2009-09-23       Impact factor: 3.133

5.  In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation.

Authors:  Stephen C B Lim; Michael J Paech; Bruce Sunderland; Yandi Liu
Journal:  Drug Des Devel Ther       Date:  2013-04-12       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.